The forecasted data indicates a consistent decline in the prevalence of tuberculosis in the US from 2024 to 2028. In 2023, the prevalence stood at 1.5 cases per hundred thousand persons. Year-on-year, the forecast shows a decrease from 1.3 cases in 2024 to 0.4 cases by 2028. This indicates significant advancements in public health initiatives and improved healthcare access. Over the last two years, the average annual decline rate is approximately 30%, while the compound annual growth rate (CAGR) over the five-year period is estimated at around -24%.
Future trends to watch for include the impact of emerging technologies in diagnostics, the rate of adoption of new tuberculosis vaccines, and the continued efforts in public health education. Monitoring these elements can provide insights into sustaining or accelerating the decline in tuberculosis prevalence.
